in Short

Rwanda : BIoNTech inaugurates an mRNA vaccine production site in Kigali

BioNTech announces the inauguration of a messenger RNA (mRNA) vaccine manufacturing facility in Kigali, Rwanda. The inauguration coincides with the opening of the first production unit, named BioNTainer. The Group’s aim is to “help build a sustainable and resilient African vaccine ecosystem and support equitable access to new medicines worldwide”. The site could become the continent’s first commercial-scale mRNA manufacturing plant.

BioNTech plans to complete all site buildings and begin training specialized personnel in 2024, with experimental mRNA production to be launched in 2025.

Articles similaires

Laisser un commentaire

Bouton retour en haut de la page